Aims and scope

The British Journal of Ophthalmology is an international peer-reviewed journal for ophthalmologists and visual science specialists describing clinical investigations, clinical observations, and clinically relevant laboratory investigations related to ophthalmology. Main features include articles on both clinical and laboratory sciences, up to date major reviews, editorials, education articles and letters. There are sections for ‘Innovations’ and ‘Global issues’ where surgical, diagnostic and therapeutic innovations and manuscripts of regional interest to geographic areas of the world respectively, are published.



British Journal of Ophthalmology is owned by BMJ.


Journal statistics 2015

Acceptance Rate

23% for Original Research

Instant Reject Rate

43% for all papers, receiving a decision within 1-3 days

Time from Submission to First Decision

5 weeks

Time from Submission to Final Decision

17 weeks

Time from Acceptance to Publication

16 days (online)



Impact Factor


Indexed By

Index Medicus (Medline), ISI Current Contents (Web of Science), Excerpta Medica (Embase)

Launch Date




ISSN (Online)



Contact information

For all contact information please refer to the Contact Us page.


For authors

Please refer to the Instructions for Authors.


To advertise

Information on rates and how to advertise in BJO.
General advertising information for BMJ.



Information on how to subscribe.


Rights and permissions

Copyright and Permissions Guidelines.



COPE logo

BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.


The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.



BMJ sites

BMJ Open Ophthalmology